Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)

GND
1187679631
ORCID
0000-0002-9994-6204
Zugehörigkeit
Department of Neurosurgery, University Hospital Duesseldorf, 40225 Duesseldorf, Germany; Katharina.Koch@IUF-Duesseldorf.de (K.K.); Dayana.Herrera-Rios@uk-essen.de (D.H.R.); Michael.Sabel@med.uni-duesseldorf.de (M.S.); Hans-Jakob.Steiger@med.uni-duesseldorf.de (H.-J.S.); ulf.kahlert@med.ovgu.de (U.D.K.)
Koch, Katharina;
GND
1217805672
ORCID
0000-0001-7807-6273
Zugehörigkeit
Institute of Biological Information Processing (IBI-7) Structural Biochemistry, Forschungszentrum Juelich, 52425 Juelich, Germany; r.hartmann@fz-juelich.de (R.H.); d.willbold@fz-juelich.de (D.W.)
Hartmann, Rudolf;
Zugehörigkeit
Department of Neurological Surgery, Helen Diller Research Center, University of California San Francisco, San Francisco, CA 94158, USA; abigail.suwala@med.uni-heidelberg.de
Suwala, Abigail Kora;
GND
1219598496
Zugehörigkeit
Department of Neurosurgery, University Hospital Duesseldorf, 40225 Duesseldorf, Germany; Katharina.Koch@IUF-Duesseldorf.de (K.K.); Dayana.Herrera-Rios@uk-essen.de (D.H.R.); Michael.Sabel@med.uni-duesseldorf.de (M.S.); Hans-Jakob.Steiger@med.uni-duesseldorf.de (H.-J.S.); ulf.kahlert@med.ovgu.de (U.D.K.)
Rios, Dayana Herrera;
GND
133492672
Zugehörigkeit
Department of Neurosurgery, Centre of Neuro-Oncology, Jena University Hospital, Friedrich-Schiller-University Jena, 07747 Jena, Germany; MarcelAlexander.Kamp@med.uni-jena.de
Kamp, Marcel Alexander;
GND
112035417X
Zugehörigkeit
Department of Neurosurgery, University Hospital Duesseldorf, 40225 Duesseldorf, Germany; Katharina.Koch@IUF-Duesseldorf.de (K.K.); Dayana.Herrera-Rios@uk-essen.de (D.H.R.); Michael.Sabel@med.uni-duesseldorf.de (M.S.); Hans-Jakob.Steiger@med.uni-duesseldorf.de (H.-J.S.); ulf.kahlert@med.ovgu.de (U.D.K.)
Sabel, Michael;
GND
1145654908
Zugehörigkeit
Department of Neurosurgery, University Hospital Duesseldorf, 40225 Duesseldorf, Germany; Katharina.Koch@IUF-Duesseldorf.de (K.K.); Dayana.Herrera-Rios@uk-essen.de (D.H.R.); Michael.Sabel@med.uni-duesseldorf.de (M.S.); Hans-Jakob.Steiger@med.uni-duesseldorf.de (H.-J.S.); ulf.kahlert@med.ovgu.de (U.D.K.)
Steiger, Hans-Jakob;
GND
1018389911
ORCID
0000-0002-0065-7366
Zugehörigkeit
Institute of Biological Information Processing (IBI-7) Structural Biochemistry, Forschungszentrum Juelich, 52425 Juelich, Germany; r.hartmann@fz-juelich.de (R.H.); d.willbold@fz-juelich.de (D.W.)
Willbold, Dieter;
ORCID
0000-0002-2216-5389
Zugehörigkeit
Department of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany; Amit.Sharma@ukbonn.de
Sharma, Amit;
GND
1025313771
ORCID
0000-0002-6021-1841
Zugehörigkeit
Department of Neurosurgery, University Hospital Duesseldorf, 40225 Duesseldorf, Germany; Katharina.Koch@IUF-Duesseldorf.de (K.K.); Dayana.Herrera-Rios@uk-essen.de (D.H.R.); Michael.Sabel@med.uni-duesseldorf.de (M.S.); Hans-Jakob.Steiger@med.uni-duesseldorf.de (H.-J.S.); ulf.kahlert@med.ovgu.de (U.D.K.)
Kahlert, Ulf Dietrich;
Zugehörigkeit
Department of Neurosurgery, University Hospital Bonn, 53127 Bonn, Germany; Amit.Sharma@ukbonn.de
Maciaczyk, Jarek

Simple Summary Glioblastoma (GBM) is the most aggressive form of glioma (WHO grade IV), and mounting evidence suggests that glioblastoma stem-like cells (GSCs) play an important role in tumor growth and response to therapy. In the current study, we sought to understand the metabolic dependencies of GSCs using high-resolution proton magnetic resonance spectroscopy ( 1 H-NMR). In a defined experimental setting, we stratified in vitro GSC models into two subtypes (Gln/Glu High , Gln/Glu Low ) and used diverse molecular approaches to perform comprehensive analyses in GSC neurosphere cultures and primary GBM samples. Abstract Cancer stem-like cells mediate tumor initiation, progression, and therapy resistance; however, their identification and selective eradication remain challenging. Herein, we analyze the metabolic dependencies of glioblastoma stem-like cells (GSCs) with high-resolution proton nuclear magnetic resonance ( 1 H-NMR) spectroscopy. We stratify our in vitro GSC models into two subtypes primarily based on their relative amount of glutamine in relationship to glutamate (Gln/Glu). Gln/Glu High GSCs were found to be resistant to glutamine deprivation, whereas Gln/Glu Low GSCs respond with significantly decreased in vitro clonogenicity and impaired cell growth. The starvation resistance appeared to be mediated by an increased expression of the glutamate/cystine antiporter SLC7A11/xCT and efficient cellular clearance of reactive oxygen species (ROS). Moreover, we were able to directly correlate xCT-dependent starvation resistance and high Gln/Glu ratios with in vitro clonogenicity, since targeted differentiation of GSCs with bone morphogenic protein 4 (BMP4) impaired xCT expression, decreased the Gln/Glu ratio, and restored the sensitivity to glutamine starvation. Moreover, significantly reduced levels of the oncometabolites lactate (Lac), phosphocholine (PC), total choline (tCho), myo-inositol (Myo-I), and glycine (Gly) were observed in differentiated GSCs. Furthermore, we found a strong association between high Gln/Glu ratios and increased expression of Zinc finger E-box-binding homeobox 1 (ZEB1) and xCT in primary GBM tumor tissues. Our analyses suggest that the inhibition of xCT represents a potential therapeutic target in glioblastoma; thus, we could further extend its importance in GSC biology and stress responses. We also propose that monitoring of the intracellular Gln/Glu ratio can be used to predict nutrient stress resistance.

Zitieren

Zitierform:
Zitierform konnte nicht geladen werden.

Rechte

Rechteinhaber: © 2021 by the authors.

Nutzung und Vervielfältigung:
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.